Work

Supplementary Figure 4 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 469K, HER2 targeted drugs, lapatinib or neratinib, inhibit the spiculated and invasive-appearing morphology of MCF10A-HER2 mutants cells

DOI: 10.1158/2159-8290.22528733.v1

Authors: Ron Bose, Shyam M. Kavuri, Adam C. Searleman, Wei Shen, Dong Shen, Daniel C. Koboldt, John Monsey, Nicholas Goel, Adam B. Aronson, Shunqiang Li, Cynthia X. Ma, Li Ding, Elaine R. Mardis, Matthew J. Ellis

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362543136

Cites:

Cited by:

Related to: 10